Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance
- PMID: 39681549
- PMCID: PMC11649685
- DOI: 10.1038/s41467-024-54568-5
Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance
Abstract
The environmental use of azole fungicides has led to selective sweeps across multiple loci in the Aspergillus fumigatus genome causing the rapid global expansion of a genetically distinct cluster of resistant genotypes. Isolates within this cluster are also more likely to be resistant to agricultural antifungals with unrelated modes of action. Here we show that this cluster is not only multi-azole resistant but has increased propensity to develop resistance to next generation antifungals because of variants in the DNA mismatch repair system. A variant in msh6-G233A is found almost exclusively within azole resistant isolates harbouring the canonical cyp51A azole resistance allelic variant TR34/L98H. Naturally occurring isolates with this msh6 variant display up to 5-times higher rate of mutation, leading to an increased likelihood of evolving resistance to other antifungals. Furthermore, unlike hypermutator strains, the G233A variant conveys no measurable fitness cost and has become globally distributed. Our findings further suggest that resistance to next-generation antifungals is more likely to emerge within organisms that are already multi-azole resistant due to close linkage between TR34/L98H and msh6-G233A, posing a major problem due to the prospect of dual use of novel antifungals in clinical and agricultural settings.
© 2024. The Author(s).
Conflict of interest statement
Competing interests: M.J.Br. is a former employee of F2G Ltd (to 2008) and has received funding from F2G Ltd for a Ph.D. studentship. The remaining authors declare no competing interests.
Figures
References
-
- Life Worldwide. Invasive Aspergillosis & Mucormycosis. http://en.fungaleducation.org/invasive-aspergillosis-mucormycosis/ (2023).
-
- Gaffi—Global action for fungal infections. Fungal Disease Frequency—Gaffi. https://gaffi.org/why/fungal-disease-frequency/ (2013).
-
- Lin, S.-J., Schranz, J. & Teutsch, S. M. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis.32, 358–366 (2001). - PubMed
-
- World Health Organization. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. https://www.who.int/publications-detail-redirect/9789240060241. (2022)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
